Pfizer Inc. (PFE)
27.98
-0.09
(-0.32%)
USD |
NYSE |
Aug 24, 16:00
27.96
-0.02
(-0.07%)
After-Hours: 20:00
Pfizer Net Income (Quarterly) : -246.00M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -246.00M |
| March 31, 2026 | 2.709B |
| December 31, 2025 | -1.64B |
| September 30, 2025 | 3.55B |
| June 30, 2025 | 2.903B |
| March 31, 2025 | 2.973B |
| December 31, 2024 | 411.00M |
| September 30, 2024 | 4.481B |
| June 30, 2024 | 31.00M |
| March 31, 2024 | 3.128B |
| December 31, 2023 | -3.335B |
| September 30, 2023 | -2.388B |
| June 30, 2023 | 2.34B |
| March 31, 2023 | 5.555B |
| December 31, 2022 | 5.001B |
| September 30, 2022 | 8.645B |
| June 30, 2022 | 9.877B |
| March 31, 2022 | 7.879B |
| December 31, 2021 | 3.578B |
| September 30, 2021 | 8.171B |
| June 30, 2021 | 5.825B |
| March 31, 2021 | 4.885B |
| December 31, 2020 | 634.00M |
| September 30, 2020 | 917.00M |
| June 30, 2020 | 2.604B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.483B |
| December 31, 2019 | -327.00M |
| September 30, 2019 | 7.68B |
| June 30, 2019 | 5.056B |
| March 31, 2019 | 3.889B |
| December 31, 2018 | -383.00M |
| September 30, 2018 | 4.111B |
| June 30, 2018 | 3.879B |
| March 31, 2018 | 3.57B |
| December 31, 2017 | 12.29B |
| September 30, 2017 | 2.858B |
| June 30, 2017 | 3.077B |
| March 31, 2017 | 3.13B |
| December 31, 2016 | 763.00M |
| September 30, 2016 | 1.355B |
| June 30, 2016 | 2.062B |
| March 31, 2016 | 3.048B |
| December 31, 2015 | -166.00M |
| September 30, 2015 | 2.13B |
| June 30, 2015 | 2.635B |
| March 31, 2015 | 2.376B |
| December 31, 2014 | 1.257B |
| September 30, 2014 | 2.676B |
| June 30, 2014 | 2.921B |
| March 31, 2014 | 2.265B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
| Merck & Co., Inc. | -1.337B |
| Bristol Myers Squibb Co. | 3.316B |
| Viatris, Inc. | -118.80M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 15.03B |
| Total Expenses (Quarterly) | 15.29B |
| EPS Diluted (Quarterly) | -0.0435 |
| Enterprise Value | 211.77B |
| Gross Profit Margin (Quarterly) | 62.94% |
| Profit Margin (Quarterly) | -1.64% |
| Earnings Yield | 2.70% |
| Operating Earnings Yield | 10.60% |
| Normalized Earnings Yield | 8.659 |